Role of Daratumumab in Combination With Standard Therapies in Patients With Relapsed and Refractory Multiple Myeloma

Multiple myeloma (MM) is a hematological malignancy characterized by renal insufficiency, bone lesions, anemia, and hypercalcemia. In this modern era of medicine, even with the development of drugs like immunomodulatory agents (IMiDs) and proteasome inhibitors (PI), the treatment of MM prevails as a...

Descripción completa

Detalles Bibliográficos
Autores principales: Bapatla, Anusha, Kaul, Arunima, Dhalla, Paramvijay Singh, Armenta-Quiroga, Ana S, Khalid, Raheela, Garcia, Jian, Khan, Safeera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204139/
https://www.ncbi.nlm.nih.gov/pubmed/34141513
http://dx.doi.org/10.7759/cureus.15440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204139/
https://www.ncbi.nlm.nih.gov/pubmed/34141513
http://dx.doi.org/10.7759/cureus.15440

Ejemplares similares